COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,699 Articles (22,913 medRxiv, 8,786 bioRxiv)

Most recent first Previous |  Page 174: Articles 1731-1740  | Next

A Phase II/III, Randomized, double-blind, placebo-controlled trial to evaluate Immunogenicity and Safety of the Gam-COVID-Vac combined vector vaccine in the prophylactic Treatment for SARS-CoV-2 infection in the United Arab Emirates
AlHammadi, A. A., Alzaabi, A. H., Choker, H. B., Ibrahim, A. A., Ishaq, A. B., Mahboub, A. E., Al Dhaheri, R. S., Alzaabi, M. N., Collyns, T. A., ElGhazali, G., Weber, S., al-Ramadi, B. K.
10.1101/2024.11.29.24318199 — Posted: 2024-12-05
Weighted analysis of symptom profile by vaccination status in positive SARS-CoV-2 cases: observational study in Sao Goncalo, Brazil
das Chagas, R. R., Freitas, H. R., Cardozo, S. V.
10.1101/2024.12.03.24318348 — Posted: 2024-12-05
Household clusters of SARS-CoV-2 Omicron subvariants contemporaneously sequenced from dogs and their owners
Ferreira, F. C., Auckland, L., Busselman, R., Davila, E., Tang, W., Lim, A., Sarbo, N., Yaglom, H. D., Centner, H., Mead, H., Tao, Y., Castro, J., Li, Y., Zhang, J., Wang, H., Malapati, L., Cook, P., Retchless, A., Tong, S., Zecca, I., Ghai, R., Barton Behravesh, C., Fischer, R., Hamer, G. L., Hamer, S.
10.1101/2024.12.02.24318339 — Posted: 2024-12-05
Changing parental perceptions to childhood immunisations during the Covid-19 pandemic in the UK: evidence from three cross-sectional surveys between 2020 and 2022
Thistlethwayte, R., de Figueiredo, A.
10.1101/2024.11.29.24318181 — Posted: 2024-12-05
Genome-wide Machine Learning Analysis of Anosmia and Ageusia with COVID-19
Pietan, L., Phillippi, E., Melo, M., El-Shanti, H., Smith, B. J., Darbro, B., Braun, T., Casavant, T.
10.1101/2024.12.04.24318493 — Posted: 2024-12-05
Ubiquitin Ligase ITCH Regulates Life Cycle of SARS-CoV-2 Virus
Xiang, Q., Wouters, C., Chang, P., Lu, Y.-N., Liu, M., Wang, H., Yang, J., Pekosz, A., Zhang, Y., Wang, J.
10.1101/2024.12.04.624804 — Posted: 2024-12-05
Optimizing a Human Monoclonal Antibody for Better Neutralization of SARS-CoV-2
Wang, Q., Guo, Y., Casner, R. G., Yu, J., Nair, M. S., Ho, J., Reddem, E. R., Tzang, C. C., Huang, Y., Shapiro, L., Liu, L., Ho, D. D.
10.1101/2024.12.04.626800 — Posted: 2024-12-05
Intra-familial dynamics of mental distress during the Covid-19 lockdown
Pettersen, J. H., Eilertsen, E. M., Hegemann, L. E., Hannigan, L. J., Lund, I. O., Johannessen, P. M., Corfield, E. C., Ystrom, E., Andreassen, O., Havdahl, A., Brandlistuen, R. E., Ask, H.
10.1101/2024.12.04.24318462 — Posted: 2024-12-05
Optimal intervention strategies for a new pandemic: The case of Covid-19
Holden, S., Ro, G., Hjort, I.
10.1101/2024.12.04.24318460 — Posted: 2024-12-05
Widespread gene-environment interactions shape the immune response to SARS-CoV-2 infection in hospitalized COVID-19 patients
Randolph, H. E., Aguirre-Gamboa, R., Brunet-Ratnasingham, E., Nakanishi, T., Locher, V., Ketter, E., Brandolino, C., Larochelle, C., Prat, A., Arbour, N., Dumaine, A., Finzi, A., Durand, M., Richards, J. B., Kaufmann, D. E., Barreiro, L. B.
10.1101/2024.12.03.626676 — Posted: 2024-12-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).